HOUSE DOCKET, NO. 2366        FILED ON: 1/17/2013

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 1818

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Martin J. Walsh

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act relative to Medicaid spending.

_______________

PETITION OF:

 

Name:

District/Address:

Date Added:

Martin J. Walsh

13th Suffolk

1/17/2013


HOUSE DOCKET, NO. 2366        FILED ON: 1/17/2013

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 1818

By Mr. Walsh of Boston, a petition (accompanied by bill, House, No. 1818) of Martin J. Walsh for legislation to require the Office of Medicaid to conduct a study of all medication-assisted treatments for opioid addiction.  Mental Health and Substance Abuse.

 

The Commonwealth of Massachusetts

 

_______________

In the Year Two Thousand Thirteen

_______________

 

An Act relative to Medicaid spending.

 

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

SECTION 1. Notwithstanding any general or special law to the contrary, the Department of Medicaid, in conjunction with the Center for Health Information and Analysis and the Bureau of Substance Abuse Services, shall conduct a study of all medicated assisted treatments paid for by the Department of Medicaid for the treatment of opioid dependence.

Said study shall include, but not be limited to, the annual expenditures to the Commonwealth for each approved medication, including total health care utilization, readmission rates, transportation and associated total costs, for clients prescribed each medicated assisted treatment, an estimation of the total number of Medicaid clients on each of the approved medicated assisted treatments, and the identification of any obstacles and corresponding solutions for state licensed providers to implement the approved medications. 

The Department of Medicaid shall report to the General Court the results of its study and its recommendations, together with drafts of legislation necessary to carry out its recommendations, by filing the same with the Clerks of the Senate and House of Representatives, the House Committee on Ways and Means, the Senate Committee on Ways and Means, the Joint Committee on Health Care Financing, the Joint Committee on Mental Health and Substance Abuse, the Health Policy Commission and the Secretary of Administration and Finance no later than December 31, 2013.